Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pheochromocytoma × Adrenalectomy × Clear all

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Adrenal Gland Neoplasms 2 Urinary Bladder Neoplasms 1 Pheochromocytoma 1 Carcinoma, Renal Cell 1

Interventions

3-Iodobenzylguanidine 4 Phenoxybenzamine 2 Ifosfamide 2 Filgrastim 2 Everolimus 2 Doxorubicin 2 Doxazosin 2 Dexmedetomidine 2 vatalanib 1 temsirolimus 1 pegfilgrastim 1 lenvatinib 1 fostamatinib 1 cabozantinib 1 atezolizumab 1 Vinorelbine 1 Temozolomide 1 Stem Cell Transplantation 1 Sirolimus 1 Saline Solution 1 Radiotherapy 1 Oxaliplatin 1 Observation 1 Melphalan 1 Leucovorin 1 Iodine-131 1 High-Energy Shock Waves 1 Granulocyte Colony-Stimulating Factor 1 Floxuridine 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06062082 2025-02-13

HEMODADRE

Central Hospital, Nancy, France

Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡